<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39327583</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1477-7517</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Harm reduction journal</Title><ISOAbbreviation>Harm Reduct J</ISOAbbreviation></Journal><ArticleTitle>Assessing stigma: Health and social worker regard towards working with people using illicit drugs in Athens, Greece.</ArticleTitle><Pagination><StartPage>175</StartPage><MedlinePgn>175</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">175</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12954-024-01091-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">After the 2008 Global Financial Crisis and resulting economic austerity, the rise in illicit drug use engendered an increased need for people who use drugs (PWUD) to access medical care, compounded by the COVID-19 pandemic. Research shows that perceptions of medical staff towards PWUD facilitate or act as a barrier to accessing health care. This study provides a better understanding of health and social work professionals' perceptions by assessing stigma levels towards PWUD in Athens, Greece.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a mixed-method study. It calculates the stigma score for professionals (n = 60) and the stigma score associated with specific drugs based on the Medical Condition Regard Scale through a quantitative analysis of responses to a semi-structured online survey about attitudes of health and social work professionals towards PWUD. It draws on the qualitative analysis of 12 semi-structured interviews with 16 service managers, providers, and health services advocates working in the charity sector to determine whether perceptions of PWUD affect writing and implementing policy and protocols for services.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Stigma towards PWUD exists amongst health and social work professionals in Athens. Professionals who have worked with PWUD for longer periods of time, professionals who have had specific training on working with PWUD, and professionals who feel that they have the necessary training to work with PWUD all demonstrated a higher stigma score than those reporting the opposite. Cannabis and opioids were associated with lower stigma scores while shisha had the highest level of stigma associated with it. Finally, professional environments are not conducive to alleviating stigma as the lack of training specific to stigma, the lack of professional supervision, and worker burn-out are key barriers faced by professionals in their everyday practice.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Reducing and eliminating stigma towards PWUD among health and social workers requires immediate action. Measures to be taken include: introducing training programs focused on stigma towards PWUD to healthcare providers, social workers, lawyers, police, the media; increasing professional supervision on field work for health and social workers; introducing low barrier health care and specialist units. Peers and field-focused organisations should meaningfully participate in drug and alcohol policymaking, program development, and implementation.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Temenos</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Manchester, Manchester, UK. cristina.temenos@manchester.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koutlou</LastName><ForeName>Aliki</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kyriakidou</LastName><ForeName>Sotiria</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galanaki</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Psychiatry Department, "ATTIKON" University General Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>204796/Z/16/Z ISSF Welcome ISSF 3 - EDI</GrantID><Agency>The Welcome Trust</Agency><Country /></Grant><Grant><GrantID>204796/Z/16/Z ISSF Welcome ISSF 3 - EDI</GrantID><Agency>The Welcome Trust</Agency><Country /></Grant><Grant><GrantID>204796/Z/16/Z ISSF Welcome ISSF 3 - EDI</GrantID><Agency>The Welcome Trust</Agency><Country /></Grant><Grant><GrantID>MR/V02468X/1</GrantID><Agency>UK Research and Innovation</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Harm Reduct J</MedlineTA><NlmUniqueID>101153624</NlmUniqueID><ISSNLinking>1477-7517</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013287">Illicit Drugs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057545" MajorTopicYN="Y">Social Stigma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006115" MajorTopicYN="N" Type="Geographic">Greece</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001291" MajorTopicYN="Y">Attitude of Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013287" MajorTopicYN="Y">Illicit Drugs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019966" MajorTopicYN="N">Substance-Related Disorders</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068217" MajorTopicYN="N">Social Workers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Athens</Keyword><Keyword MajorTopicYN="N">Burn-out</Keyword><Keyword MajorTopicYN="N">Greece</Keyword><Keyword MajorTopicYN="N">Healthcare professionals</Keyword><Keyword MajorTopicYN="N">Medical Condition Regard Scale</Keyword><Keyword MajorTopicYN="N">People who use drugs</Keyword><Keyword MajorTopicYN="N">Social work professionals</Keyword><Keyword MajorTopicYN="N">Stigma</Keyword><Keyword MajorTopicYN="N">Supervision</Keyword><Keyword MajorTopicYN="N">Training</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>7</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39327583</ArticleId><ArticleId IdType="pmc">PMC11426088</ArticleId><ArticleId IdType="doi">10.1186/s12954-024-01091-x</ArticleId><ArticleId IdType="pii">10.1186/s12954-024-01091-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rachiotis G, Stuckler D, McKee M, Hadjichristodoulou C. What has happened to suicides during the Greek economic crisis? Findings from an ecological study of suicides and their determinants (2003–2012). BMJ open. 2015;5(3):e007295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4386238</ArticleId><ArticleId IdType="pubmed">25807950</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Healthcare professionals’ regard towards working with patients with substance use disorders: comparison of primary care, general psychiatry and specialist addiction services. Drug Alcohol Depend. 2014;134:92–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24099970</ArticleId></ArticleIdList></Reference><Reference><Citation>McCann E, Temenos C. Mobilizing drug consumption rooms: inter-place networks and harm reduction drug policy. Health Place. 2015;31:216–23.</Citation><ArticleIdList><ArticleId IdType="pubmed">25576837</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirley-Beavan S, Roig A, Burke-Shyne N, Daniels C, Csak R. Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain. Harm Reduct J. 2020;17(1):1–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7574529</ArticleId><ArticleId IdType="pubmed">33076931</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang LH, Wong LY, Grivel MM, Hasin DS. Stigma and substance use disorders: an international phenomenon. Curr Opin Psychiatry. 2017;30(5):378–88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854406</ArticleId><ArticleId IdType="pubmed">28700360</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilchrist G, Moskalewicz J, Slezakova S, Okruhlica L, Torrens M, Vajd R, et al. Staff regard towards working with substance users: a European multi-centre study. Addiction. 2011;106(6):1114–25.</Citation><ArticleIdList><ArticleId IdType="pubmed">21320230</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Boekel LC, Brouwers EP, Van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1–2):23–35.</Citation><ArticleIdList><ArticleId IdType="pubmed">23490450</ArticleId></ArticleIdList></Reference><Reference><Citation>Cernasev A, Kline KM, Barenie RE, Hohmeier KC, Stewart S, Forrest-Bank SS. Healthcare Professional Students’ perspectives on Substance Use disorders and Stigma: a qualitative study. Int J Environ Res Public Health. 2022;19(5):2776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8909966</ArticleId><ArticleId IdType="pubmed">35270468</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan Carusone S, Guta A, Robinson S, Tan DH, Cooper C, O’Leary B, et al. Maybe if I stop the drugs, then maybe they’d care?-hospital care experiences of people who use drugs. Harm Reduct J. 2019;16(1):16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6373073</ArticleId><ArticleId IdType="pubmed">30760261</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvert S, Goldszmidt M, Liu L, Burm S, Cristancho S, Torti J, et al. Exploring the process of care for people who inject drugs in hospital settings. Drugs: Educ Prev Policy. 2023;30(6):583–92.</Citation></Reference><Reference><Citation>Gunner E, Chandan SK, Marwick S, Saunders K, Burwood S, Yahyouche A, et al. Provision and accessibility of primary healthcare services for people who are homeless: a qualitative study of patient perspectives in the UK. Br J Gen Pract. 2019;69(685):e526–36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6650120</ArticleId><ArticleId IdType="pubmed">31307999</ArticleId></ArticleIdList></Reference><Reference><Citation>Muncan B, Walters SM, Ezell J, Ompad DC. They look at us like junkies: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020;17(1):53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7393740</ArticleId><ArticleId IdType="pubmed">32736624</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajab D, Fujioka JK, Walker M, Bartels SA, MacKenzie M, Purkey E. Emergency department care experiences among people who use substances: a qualitative study. Int J Equity Health. 2023;22(1):248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10696685</ArticleId><ArticleId IdType="pubmed">38049838</ArticleId></ArticleIdList></Reference><Reference><Citation>Strike C, Robinson S, Guta A, Tan DH, O’Leary B, Cooper C, et al. Illicit drug use while admitted to hospital: patient and health care provider perspectives. PLoS ONE. 2020;15(3):e0229713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7058273</ArticleId><ArticleId IdType="pubmed">32134973</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutherland R, King C, Karlsson A, Treloar C, Broady T, Chandrasena U, et al. Stigma, and factors associated with experiencing stigma, while visiting health-care services among samples of people who use illegal drugs in Australia. Drug Alcohol Rev. 2024;43(5):1264–79.</Citation><ArticleIdList><ArticleId IdType="pubmed">38644679</ArticleId></ArticleIdList></Reference><Reference><Citation>Armaos R, Tsiboukli A. Medical students’ training needs and attitudes on substance abuse: implications for medical education in Greece. Drugs: Educ Prev Policy. 2019;26(6):508–16.</Citation></Reference><Reference><Citation>Andreu M, Alcaraz N, Gual A, Segura L, Barrio P. Primary care provider expectations of addiction services and patients in Spain. Fam Pract. 2022;39(2):269–74.</Citation><ArticleIdList><ArticleId IdType="pubmed">34089055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezell JM, Walters S, Friedman SR, Bolinski R, Jenkins WD, Schneider J, et al. Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities. Soc Sci Med. 2021;268:113470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755701</ArticleId><ArticleId IdType="pubmed">33253992</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancaster KE, Endres-Dighe S, Sucaldito AD, Piscalko H, Madhu A, Kiriazova T, et al. Measuring and addressing stigma within HIV interventions for people who use drugs: a scoping review of recent research. Curr HIV/AIDS Rep. 2022;19(5):301–11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10546998</ArticleId><ArticleId IdType="pubmed">36048310</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo S, Lin C, Feng N, Wu Z, Li L. Stigma towards people who use drugs: a case vignette study in methadone maintenance treatment clinics in China. Int J Drug Policy. 2019;71:73–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6868318</ArticleId><ArticleId IdType="pubmed">31233972</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunlop A, Lokuge B, Masters D, Sequeira M, Saul P, Dunlop G, et al. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduct J. 2020;17(1):1–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201394</ArticleId><ArticleId IdType="pubmed">32375887</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquette CE, Syvertsen JL, Pollini RA. Stigma at every turn: health services experiences among people who inject drugs. Int J Drug Policy. 2018;57:104–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5994194</ArticleId><ArticleId IdType="pubmed">29715589</ArticleId></ArticleIdList></Reference><Reference><Citation>EMCDDA. Greece Country Drug Report 2019. https://www.emcdda.europa.eu/publications/country-drug-reports/2019/greece_en</Citation></Reference><Reference><Citation>Kentikelenis A, Karanikolos M, Papanicolas I, Basu S, McKee M, Stuckler D. Health effects of financial crisis: omens of a Greek tragedy. Lancet. 2011;378(9801):1457–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21988763</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantos P, Papanastasatos G, Poulopoulos C, Zaxaropoulos Y. Patterns of use and perceptions of drug addicts in Greece about Shisha(a new synthetic drug) at economic crisis era. Drugs Alcohol Today. 2014;14(1):10–8.</Citation></Reference><Reference><Citation>EMCDDA. Statistical Bulletin. 2023 - treatment demand 2023. https://www.emcdda.europa.eu/data/stats2023/tdi_en#displayTable:TDI-0311</Citation></Reference><Reference><Citation>EMCDDA. Drug-related hospital emergency presentations in Europe: update from the Euro-DEN Plus expert network. Luxembourg; 2020.</Citation></Reference><Reference><Citation>Process of translation and adaptation of instruments [Internet]. 2012. http://www.who.int/substance_abuse/research_tools/translation/en/</Citation></Reference><Reference><Citation>Christison GW, Haviland MG, Riggs ML. The medical condition regard scale: measuring reactions to diagnoses. Acad Med. 2002;77(3):257–62.</Citation><ArticleIdList><ArticleId IdType="pubmed">11891166</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducray K, Pilch M. Health student regard for substance-using patients as measured by the Medical Condition Regard Scale: a systematic review. Ir J Psychol Med. 2017;34(3):183–96.</Citation><ArticleIdList><ArticleId IdType="pubmed">30115150</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ. 2011;2:53–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4205511</ArticleId><ArticleId IdType="pubmed">28029643</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton MQ. Qualitative research &amp; evaluation methods: integrating theory and practice. 4th ed. Thousand Oaks, CA: Sage; 2015.</Citation></Reference><Reference><Citation>Fereday J, Muir-Cochrane E. Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development. Int J Qualitative Methods. 2006;5(1):80–92.</Citation></Reference><Reference><Citation>McDonald N, Schoenebeck S, Forte A. Reliability and inter-rater reliability in qualitative research: norms and guidelines for CSCW and HCI practice. Proc ACM Hum Comput Interact. 2019;3(CSCW):1–23.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank D, Elliott L, Cleland CM, Walters SM, Joudrey PJ, Russell DM, et al. As safe as possible: a qualitative study of opioid withdrawal and risk behavior among people who use illegal opioids. Harm Reduct J. 2023;20(1):158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10605476</ArticleId><ArticleId IdType="pubmed">37891630</ArticleId></ArticleIdList></Reference><Reference><Citation>Temenos C. Troubling austerity: Crisis policy-making and revanchist public health politics. ACME: Int J Crit Geographies. 2022;21(6):728–49.</Citation></Reference><Reference><Citation>Marks M, Scheibe A, Shelly S. High retention in an opioid agonist therapy project in Durban, South Africa: the role of best practice and social cohesion. Harm Reduct J. 2020;17(1):1–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7161298</ArticleId><ArticleId IdType="pubmed">32295595</ArticleId></ArticleIdList></Reference><Reference><Citation>Brener L, Cama E, Broady T, Harrod ME, Holly C, Caruana T et al. Experiences of stigma and subsequent reduced access to health care among women who inject drugs. Drug Alcohol Rev. 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">38271084</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamat S, Hegarty P, Patton R. Same clinic, different conceptions: drug users’ and healthcare professionals’ perceptions of how stigma may affect clinical care. J Appl Soc Psychol. 2019;49(8):534–45.</Citation></Reference><Reference><Citation>Pelullo CP, Curcio F, Auriemma F, Cefalo G, Fabozzi A, Rossiello R, et al. The discrimination against, health status and wellness of people who use drugs in Italian services: a survey. Medicina. 2019;55(10):662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6843327</ArticleId><ArticleId IdType="pubmed">31575011</ArticleId></ArticleIdList></Reference><Reference><Citation>Skliamis K, Benschop A, Korf DJ. Cannabis users and stigma: a comparison of users from European countries with different cannabis policies. Eur J Criminol. 2022;19(6):1483–500.</Citation><ArticleIdList><ArticleId IdType="pubmed">35382693</ArticleId></ArticleIdList></Reference><Reference><Citation>Deans C, Soar R. Caring for clients with dual diagnosis in rural communities in Australia: the experience of mental health professionals. J Psychiatr Ment Health Nurs. 2005;12(3):268–74.</Citation><ArticleIdList><ArticleId IdType="pubmed">15876232</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard V, Holmshaw J. Inpatient staff perceptions in providing care to individuals with co-occurring mental health problems and illicit substance use. J Ppsychiatric Mental Health Nurs. 2010;17(10):862–72.</Citation><ArticleIdList><ArticleId IdType="pubmed">21078001</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhanani LY, Harris EL, Mirto J, Franz B. Barriers to working with patients who misuse opioids and physician burnout: implications for medical education. Subst Use Misuse. 2022;57(8):1177–84.</Citation><ArticleIdList><ArticleId IdType="pubmed">35473470</ArticleId></ArticleIdList></Reference><Reference><Citation>Unachukwu IC, Abrams MP, Dolan A, Oyekemi K, Meisel ZF, South EC, et al. The new normal has become a nonstop crisis: a qualitative study of burnout among Philadelphia’s harm reduction and substance use disorder treatment workers during the COVID-19 pandemic. Harm Reduct J. 2023;20(1):32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10008076</ArticleId><ArticleId IdType="pubmed">36906576</ArticleId></ArticleIdList></Reference><Reference><Citation>Olding M, Boyd J, Kerr T, McNeil R. And we just have to keep going: Task shifting and the production of burnout among overdose response workers with lived experience. Soc Sci Med. 2021;270:113631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168663</ArticleId><ArticleId IdType="pubmed">33418149</ArticleId></ArticleIdList></Reference><Reference><Citation>Taha S, King S, Atif S, Bate E. Changes in harm reduction service providers professional quality of life during dual public health emergencies in Canada. Harm Reduct J. 2024;21(1):48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10882723</ArticleId><ArticleId IdType="pubmed">38388932</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayon S, Jeneby F, Hamid F, Badhrus A, Abdulrahman T, Mburu G. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs. Reproductive Health. 2019;16:1–11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6538559</ArticleId><ArticleId IdType="pubmed">31138238</ArticleId></ArticleIdList></Reference><Reference><Citation>Visnegarwala F, Rodriguez-Barradass M, Graviss EA, Caprio M, Nykyforchyn M, Laufman L. Community outreach with weekly delivery of anti-retroviral drugs compared to cognitive-behavioural health care team-based approach to improve adherence among indigent women newly starting HAART. AIDS Care. 2006;18(4):332–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16809110</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>